Compound ID | 1891
Class: Beta-lactam (cephalosporin, second generation)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and against many Enterobacteriaceae; less vulnerable to extended-spectum beta-lactamases (ESBL) |
Description: | Semisynthetic Cephalosporin (cephamycin), derived from Cephalosporin C |
Year first mentioned: | 1979 |
Highest developmental phase: | Approved by FDA in 1989 |
Development status: | Discontinued |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/42008 |
Guide to Pharmacology: | cefmetazole |
Citations: |
|